-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse MünchenEURISIN US00287YDA47-
AbbvieBörse Börse MünchenISIN US00287YDA47EURSymbol 4AB
-
AbbvieBörse Börse FrankfurtISIN US00287YBP34EURSymbol 4AB
-
AbbvieBörse Börse MünchenEURISIN US00287YCT47
-
AbbvieBörse Tradegate System der Deutsche Börse AG (60%)ISIN US00287YCZ07EURSymbol 4AB
-
ABBVIE INCBörse Börse BerlinISIN US00287YBK47EURSymbol 4AB
-
ABBVIE INCBörse Börse DüsseldorfISIN US00287YCR80EURSymbol 4AB
-
ABBVIE INCBörse Quotrix System der Börse DüsseldorfISIN US00287YDB20EURSymbol 4AB
-
ABBVIE INCBörse Gettex System der Börse MünchenISIN XS2125913603EURSymbol 4AB
-
ABBVIE INCBörse Börse StuttgartISIN US00287YCU10EURSymbol 4AB
-
ISIN US00287YAU38EURSymbol ABBV
-
BRLISIN US00287YBY41
-
ISIN US00287YCS63Symbol 4AB
-
USDISIN US00287YCY32
-
USDISIN US00287YCV92
-
AbbVie Inc.Börse Bolsa Mexicana de Valore Mexiko-StadtISIN US00287YBM03
-
AbbVie Inc.Börse Bolsa de Comercio de Buenos AiresISIN US00287YBC21
-
ISIN US00287YDA47
Symbol 4AB
Währung
EUR
Börse
Börse München Zeitzone: America/Argentina/Buenos_Aires
Marktkapitalisierung
291.000.000
Mitarbeiter
50.000
Portrait der Abbvie Aktie
Das Unternehmen Abbvie aus USA beschäftigt 50.000 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Abbvie ist in mehr als 87 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) gewichtet Abbvie mit 7,03% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Abbvie Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Abbvie am höchsten gewichtet ist Insgesamt in 87 ETFs enthalten
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Abbvie?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
228 News & Informationen zur Abbvie Aktie
AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice? By StockNews
AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice?
10 Biotech Penny Stocks to Buy According to Reddit
In this article, we discuss the 10 biotech penny stocks to buy according to Reddit.
Global $191 Billion Orphan Drugs Markets To 2026: Therapeutic Applications In Rare And Orphan Diseases, Regulatory Framework, Patents, And Innovations
DUBLIN, Aug. 5, 2021 /PRNewswire/ — The
Global Cancer Therapies Market to Reach $204.2 Billion by 2024
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Diversified Portfolios, Inc. Buys Altair Engineering Inc, Vanguard ESG U.S. Stock ETF, Vanguard ESG International Stock ETF, Sells Vanguard Short-Term Bond ETF, Vanguard Intermediate-Term Bond ETF, Sh
GuruFocus Article or News written by insider and the topic is about:
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Takeda Receives Decision By The Irish Tax Appeals Commission Relating To Tax Assessment On Break Fee Shire Received From AbbVie
Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK)(“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30,
Abbvie Stock: Still Undervalued With More Room To Grow (NYSE:ABBV)
Abbvie looks like a great opportunity for dividend investors today, offering a 4.5% yield with 49 consecutive years of dividend growth. The stock appears undervalued compared to future FCF.
Groesbeck Investment Management Corp Buys M.D.C. Holdings Inc, Nexstar Media Group Inc, BlackRock Inc, Sells Sherwin-Williams Co, 3M Co, Vertex Pharmaceuticals Inc
GuruFocus Article or News written by insider and the topic is about:
Distillate Capital Partners LLC Buys Facebook Inc, AbbVie Inc, Apple Inc, Sells Walmart Inc, Applied Materials Inc, Anthem Inc
GuruFocus Article or News written by insider and the topic is about:
AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q2 2021 Results – Earnings Call Transcript
AbbVie Inc. (NYSE:ABBV) Q2 2021 Earnings Conference Call July 30, 2021, 09:00 AM ET Company Participants Liz Shea – VP of IR Rick Gonzalez – Chairman of the Board and CEO Jeff Stewart – EVP…
AbbVie to advance beta-amyloid Alzheimer's candidate, abandon (NYSE:ABBV)
AbbVie has decided to advance a candidate that will target beta-amyloid plaque in the brain as an Alzheimer's treatment, while abandoning ABBV-8E12, a phase 2 asset that targets tau.
Have $500? Here Are 2 High-Yielding Healthcare Stocks to Consider
These two companies offer impressive — and safe — yields for investors who like income.
AbbVie Inc. (ABBV) Reports Second-Quarter 2021 Financial Results
AbbVie cites growth of immunology business in the second quarter
AbbVie Inc. undefined beat expectations for the second quarter of 2021, driven largely by gains in its immunology business. The drug maker had earnings of…
AbbVie tops Q2 forecast; non-GAAP EPS outlook for FY21 raised (NYSE:ABBV)
AbbVie (ABBV) reports financial results for Q2 ended June 30, 2021, which came in ahead of analyst expectations.Worldwide net revenues were $13.96B, an increase of 33.9% over Q2…
AbbVie raises annual profit forecast as Botox demand rebounds
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
AbbVie raises annual profit forecast as Botox demand rebounds By Reuters
AbbVie raises annual profit forecast as Botox demand rebounds
AbbVie Inc. Stock Quote (U.S.: NYSE)
ABBV | Complete AbbVie Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Nasdaq Futures 150 Pts Lower; Amazon, Pinterest Results Drag By Investing.com
Nasdaq Futures 150 Pts Lower; Amazon, Pinterest Results Drag
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter.
• …
Suncoast Equity Management Buys Edwards Lifesciences Corp, Steris PLC, AbbVie Inc, Sells Check Point Software Technologies
GuruFocus Article or News written by insider and the topic is about:
Oak Family Advisors, Llc Buys Northrop Grumman Corp, Vanguard Short-Term Inflation-Protected Securities, B2Gold Corp, Sells Weyerhaeuser Co, Dominion Energy Inc, Pfizer Inc
GuruFocus Article or News written by insider and the topic is about: